Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.

Overview of attention for article published in Diabetes Care, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 X users

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 17 X posts from 15 X users, with an upper bound of 194,917 followers.

Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19 | Diabetes Care | American Diabetes Association https://t.co/dN5CrCE9z1

RT @SFDiabete: Dans une étude 🇬🇧 rétrospective (40 centres, 2020), 3067 personnes avec #DT2 ont été hospitalisées pour #COVID19 (moy 72 ans…

RT @kamleshkhunti: Our @ABCDiab study published in @ADA_Pubs Shows high mortality rate in people with T2 diabetes admitted to hospital wit…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 13 additional X posts.